387 related articles for article (PubMed ID: 26130118)
1. Mitomycin-Induced Pulmonary Veno-Occlusive Disease: Evidence From Human Disease and Animal Models.
Perros F; Günther S; Ranchoux B; Godinas L; Antigny F; Chaumais MC; Dorfmüller P; Hautefort A; Raymond N; Savale L; Jaïs X; Girerd B; Cottin V; Sitbon O; Simonneau G; Humbert M; Montani D
Circulation; 2015 Sep; 132(9):834-47. PubMed ID: 26130118
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Human and Experimental Pulmonary Veno-Occlusive Disease.
Manaud G; Nossent EJ; Lambert M; Ghigna MR; Boët A; Vinhas MC; Ranchoux B; Dumas SJ; Courboulin A; Girerd B; Soubrier F; Bignard J; Claude O; Lecerf F; Hautefort A; Florio M; Sun B; Nadaud S; Verleden SE; Remy S; Anegon I; Bogaard HJ; Mercier O; Fadel E; Simonneau G; Vonk Noordegraaf A; Grünberg K; Humbert M; Montani D; Dorfmüller P; Antigny F; Perros F
Am J Respir Cell Mol Biol; 2020 Jul; 63(1):118-131. PubMed ID: 32209028
[TBL] [Abstract][Full Text] [Related]
3. Characteristics and Long-term Outcomes of Pulmonary Venoocclusive Disease Induced by Mitomycin C.
Certain MC; Chaumais MC; Jaïs X; Savale L; Seferian A; Parent F; Georges M; Favrolt N; Bourdin A; Boissin C; Cottin V; Traclet J; Renard S; Noel V; Picard F; Girerd B; Ghigna MR; Perros F; Sitbon O; Bonniaud P; Humbert M; Montani D
Chest; 2021 Mar; 159(3):1197-1207. PubMed ID: 32979348
[TBL] [Abstract][Full Text] [Related]
4. A simple method to assess in vivo proliferation in lung vasculature with EdU: the case of MMC-induced PVOD in rat.
Fabrice A; Benoît R; Valérie N; Lau E; Sébastien B; Frédéric P
Anal Cell Pathol (Amst); 2015; 2015():326385. PubMed ID: 26345623
[TBL] [Abstract][Full Text] [Related]
5. Mitomycin C induces pulmonary vascular endothelial-to-mesenchymal transition and pulmonary veno-occlusive disease via Smad3-dependent pathway in rats.
Zhang C; Lu W; Luo X; Liu S; Li Y; Zheng Q; Liu W; Wu X; Chen Y; Jiang Q; Zhang Z; Gu G; Chen J; Chen H; Liao J; Liu C; Hong C; Tang H; Sun D; Yang K; Wang J
Br J Pharmacol; 2021 Jan; 178(1):217-235. PubMed ID: 33140842
[TBL] [Abstract][Full Text] [Related]
6. [Mitomycin-induced pulmonary veno-occlusive disease: A rare but severe complication].
Montani D; Chaumais MC; Seferian A; Humbert M
Bull Cancer; 2017 Feb; 104(2):202-204. PubMed ID: 27884394
[No Abstract] [Full Text] [Related]
7. Clinical phenotypes and outcomes of heritable and sporadic pulmonary veno-occlusive disease: a population-based study.
Montani D; Girerd B; Jaïs X; Levy M; Amar D; Savale L; Dorfmüller P; Seferian A; Lau EM; Eyries M; Le Pavec J; Parent F; Bonnet D; Soubrier F; Fadel E; Sitbon O; Simonneau G; Humbert M
Lancet Respir Med; 2017 Feb; 5(2):125-134. PubMed ID: 28087362
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary vascular remodeling patterns and expression of general control nonderepressible 2 (GCN2) in pulmonary veno-occlusive disease.
Nossent EJ; Antigny F; Montani D; Bogaard HJ; Ghigna MR; Lambert M; Thomas de Montpréville V; Girerd B; Jaïs X; Savale L; Mercier O; Fadel E; Soubrier F; Sitbon O; Simonneau G; Vonk Noordegraaf A; Humbert M; Perros F; Dorfmüller P
J Heart Lung Transplant; 2018 May; 37(5):647-655. PubMed ID: 29108819
[TBL] [Abstract][Full Text] [Related]
9. GCN2 Regulates ATF3-p38 MAPK Signaling Transduction in Pulmonary Veno-Occlusive Disease.
Chen Z; Zhang J; Wei D; Chen J; Yang J
J Cardiovasc Pharmacol Ther; 2021 Nov; 26(6):677-689. PubMed ID: 33988041
[TBL] [Abstract][Full Text] [Related]
10. Mitomycin induced pulmonary veno-occlusive disease.
Kunadu A; Stalls JS; Labuschagne H; Thayyil A; Falls R; Maddipati V
Respir Med Case Rep; 2021; 34():101437. PubMed ID: 34401312
[TBL] [Abstract][Full Text] [Related]
11. [Pulmonary veno-occlusive disease].
Boucly A; Girerd B; Bourlier D; Nemlaghi S; Caliez J; Savale L; Jaïs X; Dorfmüller P; Simonneau G; Sitbon O; Humbert M; Montani D
Rev Mal Respir; 2018 Feb; 35(2):160-170. PubMed ID: 29501213
[TBL] [Abstract][Full Text] [Related]
12. Response to Letter Regarding Article, "Mitomycin-Induced Pulmonary Veno-Occlusive Disease: Evidence From Human Disease and Animal Model".
Perros F; Günther S; Ranchoux B; Godinas L; Antigny F; Chaumais MC; Dorfmüller P; Hautefort A; Raymond N; Savale L; Jaïs X; Girerd B; Cottin V; Sitbon O; Simonneau G; Humbert M; Montani D
Circulation; 2016 Apr; 133(14):e592-3. PubMed ID: 27045136
[No Abstract] [Full Text] [Related]
13. Pulmonary veno-occlusive disease after neoadjuvant mitomycin chemotherapy and surgery for lung carcinoma.
Gagnadoux F; Capron F; Lebeau B
Lung Cancer; 2002 May; 36(2):213-5. PubMed ID: 11955658
[TBL] [Abstract][Full Text] [Related]
14. Letter by Belge et al Regarding Article, "Mitomycin-Induced Pulmonary Veno-Occlusive Disease: Evidence From Human Disease and Animal Models".
Belge C; Quarck R; Delcroix M
Circulation; 2016 Apr; 133(14):e591. PubMed ID: 27045135
[No Abstract] [Full Text] [Related]
15. Chemotherapy-induced pulmonary hypertension: role of alkylating agents.
Ranchoux B; Günther S; Quarck R; Chaumais MC; Dorfmüller P; Antigny F; Dumas SJ; Raymond N; Lau E; Savale L; Jaïs X; Sitbon O; Simonneau G; Stenmark K; Cohen-Kaminsky S; Humbert M; Montani D; Perros F
Am J Pathol; 2015 Feb; 185(2):356-71. PubMed ID: 25497573
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary veno-occlusive disease as a cause of severe pulmonary hypertension in a dog.
den Toom ML; Grinwis G; van Suylen RJ; Boroffka SA; de Jong P; van Steenbeek FG; Szatmári V
Acta Vet Scand; 2018 Dec; 60(1):78. PubMed ID: 30518401
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary veno-occlusive disease: pathogenesis, risk factors, clinical features and diagnostic algorithm - state of the art.
Szturmowicz M; Kacprzak A; Szołkowska M; Burakowska B; Szczepulska E; Kuś J
Adv Respir Med; 2018; 86(3):. PubMed ID: 29960280
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis and management of pulmonary veno-occlusive disease.
Solinas S; Boucly A; Beurnier A; Kularatne M; Grynblat J; Eyries M; Dorfmüller P; Sitbon O; Humbert M; Montani D
Expert Rev Respir Med; 2023; 17(8):635-649. PubMed ID: 37578057
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary veno-occlusive disease.
Montani D; Lau EM; Dorfmüller P; Girerd B; Jaïs X; Savale L; Perros F; Nossent E; Garcia G; Parent F; Fadel E; Soubrier F; Sitbon O; Simonneau G; Humbert M
Eur Respir J; 2016 May; 47(5):1518-34. PubMed ID: 27009171
[TBL] [Abstract][Full Text] [Related]
20. EIF2AK4 mutations cause pulmonary veno-occlusive disease, a recessive form of pulmonary hypertension.
Eyries M; Montani D; Girerd B; Perret C; Leroy A; Lonjou C; Chelghoum N; Coulet F; Bonnet D; Dorfmüller P; Fadel E; Sitbon O; Simonneau G; Tregouët DA; Humbert M; Soubrier F
Nat Genet; 2014 Jan; 46(1):65-9. PubMed ID: 24292273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
